267 related articles for article (PubMed ID: 28957419)
1. Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.
Tartour K; Nguyen XN; Appourchaux R; Assil S; Barateau V; Bloyet LM; Burlaud Gaillard J; Confort MP; Escudero-Perez B; Gruffat H; Hong SS; Moroso M; Reynard O; Reynard S; Decembre E; Ftaich N; Rossi A; Wu N; Arnaud F; Baize S; Dreux M; Gerlier D; Paranhos-Baccala G; Volchkov V; Roingeard P; Cimarelli A
PLoS Pathog; 2017 Sep; 13(9):e1006610. PubMed ID: 28957419
[TBL] [Abstract][Full Text] [Related]
2. Functional Heterogeneity of Mammalian IFITM Proteins against HIV-1.
Marziali F; Delpeuch M; Kumar A; Appourchaux R; Dufloo J; Tartour K; Etienne L; Cimarelli A
J Virol; 2021 Aug; 95(18):e0043921. PubMed ID: 34160255
[TBL] [Abstract][Full Text] [Related]
3. IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
Tartour K; Appourchaux R; Gaillard J; Nguyen XN; Durand S; Turpin J; Beaumont E; Roch E; Berger G; Mahieux R; Brand D; Roingeard P; Cimarelli A
Retrovirology; 2014 Nov; 11():103. PubMed ID: 25422070
[TBL] [Abstract][Full Text] [Related]
4. Functional Mapping of Regions Involved in the Negative Imprinting of Virion Particle Infectivity and in Target Cell Protection by Interferon-Induced Transmembrane Protein 3 against HIV-1.
Appourchaux R; Delpeuch M; Zhong L; Burlaud-Gaillard J; Tartour K; Savidis G; Brass A; Etienne L; Roingeard P; Cimarelli A
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355696
[TBL] [Abstract][Full Text] [Related]
5. Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment.
Xie M; Xuan B; Shan J; Pan D; Sun Y; Shan Z; Zhang J; Yu D; Li B; Qian Z
J Virol; 2015 Mar; 89(6):3049-61. PubMed ID: 25552713
[TBL] [Abstract][Full Text] [Related]
6. The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.
Wang Y; Pan Q; Ding S; Wang Z; Yu J; Finzi A; Liu SL; Liang C
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100616
[TBL] [Abstract][Full Text] [Related]
7. Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
Foster TL; Wilson H; Iyer SS; Coss K; Doores K; Smith S; Kellam P; Finzi A; Borrow P; Hahn BH; Neil SJD
Cell Host Microbe; 2016 Oct; 20(4):429-442. PubMed ID: 27640936
[TBL] [Abstract][Full Text] [Related]
8. Virion Background and Efficiency of Virion Incorporation Determine Susceptibility of Simian Immunodeficiency Virus Env-Driven Viral Entry to Inhibition by IFITM Proteins.
Wrensch F; Hoffmann M; Gärtner S; Nehlmeier I; Winkler M; Pöhlmann S
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807233
[TBL] [Abstract][Full Text] [Related]
9. Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV.
Wilkins J; Zheng YM; Yu J; Liang C; Liu SL
PLoS One; 2016; 11(6):e0156739. PubMed ID: 27257969
[TBL] [Abstract][Full Text] [Related]
10. IFITM1 and IFITM3 Proteins Inhibit the Infectivity of Progeny HIV-1 without Disrupting Envelope Glycoprotein Clusters.
Verma S; Chen YC; Marin M; Gillespie SE; Melikyan GB
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140631
[TBL] [Abstract][Full Text] [Related]
11. Membrane Interference Against HIV-1 by Intrinsic Antiviral Factors: The Case of IFITMs.
Marziali F; Cimarelli A
Cells; 2021 May; 10(5):. PubMed ID: 34065027
[TBL] [Abstract][Full Text] [Related]
12. Influenza A Virus Facilitates Its Infectivity by Activating p53 to Inhibit the Expression of Interferon-Induced Transmembrane Proteins.
Wang B; Lam TH; Soh MK; Ye Z; Chen J; Ren EC
Front Immunol; 2018; 9():1193. PubMed ID: 29904383
[TBL] [Abstract][Full Text] [Related]
13. Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity.
Diehl WE; Guney MH; Vanzo T; Kyawe PP; White JM; Pizzato M; Luban J
Viruses; 2021 Jun; 13(7):. PubMed ID: 34209034
[TBL] [Abstract][Full Text] [Related]
14. IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells.
Melvin WJ; McMichael TM; Chesarino NM; Hach JC; Yount JS
Viruses; 2015 Jun; 7(6):3035-52. PubMed ID: 26075508
[TBL] [Abstract][Full Text] [Related]
15. Antiviral Role of IFITM Proteins in African Swine Fever Virus Infection.
Muñoz-Moreno R; Cuesta-Geijo MÁ; Martínez-Romero C; Barrado-Gil L; Galindo I; García-Sastre A; Alonso C
PLoS One; 2016; 11(4):e0154366. PubMed ID: 27116236
[TBL] [Abstract][Full Text] [Related]
16. The Antiviral Activity of Interferon-Induced Transmembrane Proteins and Virus Evasion Strategies.
Wang J; Luo Y; Katiyar H; Liang C; Liu Q
Viruses; 2024 May; 16(5):. PubMed ID: 38793616
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins.
Chutiwitoonchai N; Hiyoshi M; Hiyoshi-Yoshidomi Y; Hashimoto M; Tokunaga K; Suzu S
Microbes Infect; 2013 Apr; 15(4):280-90. PubMed ID: 23376165
[TBL] [Abstract][Full Text] [Related]
18. IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Compton AA; Bruel T; Porrot F; Mallet A; Sachse M; Euvrard M; Liang C; Casartelli N; Schwartz O
Cell Host Microbe; 2014 Dec; 16(6):736-47. PubMed ID: 25464829
[TBL] [Abstract][Full Text] [Related]
19. Cellular Antiviral Factors that Target Particle Infectivity of HIV-1.
Goffinet C
Curr HIV Res; 2016; 14(3):211-6. PubMed ID: 26674651
[TBL] [Abstract][Full Text] [Related]
20. IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus.
Mudhasani R; Tran JP; Retterer C; Radoshitzky SR; Kota KP; Altamura LA; Smith JM; Packard BZ; Kuhn JH; Costantino J; Garrison AR; Schmaljohn CS; Huang IC; Farzan M; Bavari S
J Virol; 2013 Aug; 87(15):8451-64. PubMed ID: 23720721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
